Tenpoint Therapeutics Ltd. announced a new telehealth prescribing program that allows eligible adults experiencing blurry close-up vision to be evaluated online by an ophthalmologist or optometrist to determine whether they qualify for a prescription for carbachol and brimonidine tartrate ophthalmic solution 2.75%/0.1% (Yuvezzi).

According to a company press release, the program is designed to complement, not replace, care from eyecare professionals. Participants will be encouraged to establish and maintain care with a local ophthalmologist or optometrist for their vision and eye health needs. To facilitate access to local care, Tenpoint also launched yuvezzidoctor.com, where adults can find eyecare professionals in their area.

The telehealth prescribing program is available through orderyuvezzi.com, with prescribed eye drops shipped directly to patients' homes.

The US Food and Drug Administration approved Yuvezzi in January, and Tenpoint launched the dual-agent eye drop nationwide in March.